Development success

Stanelco PLC 16 March 2004 STANELCO, INGEL TECHNOLOGIES: RADIO FREQUENCY ENCAPSULATION Stanelco plc, the RF (radio frequency) applications group is pleased to report significant progress with its InGel Technologies Limited venture. Stanelco has successfully demonstrated the use of RF technology to rapidly manufacture soft, one-piece capsules for oral and topical (applied to skin) applications using water-soluble materials. With the success of this demonstration, the company will now design and build a pilot commercial scale machine for manufacturing capsules to nutritional- and pharmaceutical-standards, Commenting, Ian Balchin, Chief Executive of Stanelco, said: 'This is a true breakthrough in the commercial processing of water-soluble and edible materials which I believe is leading to a revolutionary new generation of commercial RF processing equipment. It is a major milestone for all parties involved and the achievement is a reflection upon the calibre and know-how of the team of people we have working for InGel - they are to be congratulated. Work is now focusing on further optimising all aspects of the processing economics prior to the anticipated commercial launch.' InGel Technologies is a co-venture between Stanelco, plc. and Cardinal Health, the leading provider of products and services for the health care industry. Notes to Editors: Stanelco was founded in 1953 and is a world leader in the design and manufacture of optical fibre furnace technology, induction heating and dielectric welding equipment. The company's current core business is the manufacture of optical fibre using RF technology. Stanelco has been applying its technology to other markets and is currently developing detergent capsules, foamed starch trays, edible sachets and waste packing. • ENDS - For further information, please contact: Ian Balchin, Chief Executive Stanelco plc - Tel: 01489 570991 Caroline Sturdy Bell Pottinger Financial - Tel: 020 7861 3232 END This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings